Gastric inhibitory polypeptide (GIP), cholecytokinin (CCK), secretin (S) effects on in vitro insulin and glucagon secretion

W. Y. Fujimoto, J. W. Ensinck, David G Johnson

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalDiabetes
Volume26
Issue numberSup 1
StatePublished - 1977
Externally publishedYes

Fingerprint

Gastric Inhibitory Polypeptide
Secretin
Glucagon
Insulin
In Vitro Techniques

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Gastric inhibitory polypeptide (GIP), cholecytokinin (CCK), secretin (S) effects on in vitro insulin and glucagon secretion. / Fujimoto, W. Y.; Ensinck, J. W.; Johnson, David G.

In: Diabetes, Vol. 26, No. Sup 1, 1977.

Research output: Contribution to journalArticle

@article{5fd08129fd3a4689b268e1410e4a7f83,
title = "Gastric inhibitory polypeptide (GIP), cholecytokinin (CCK), secretin (S) effects on in vitro insulin and glucagon secretion",
author = "Fujimoto, {W. Y.} and Ensinck, {J. W.} and Johnson, {David G}",
year = "1977",
language = "English (US)",
volume = "26",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "Sup 1",

}

TY - JOUR

T1 - Gastric inhibitory polypeptide (GIP), cholecytokinin (CCK), secretin (S) effects on in vitro insulin and glucagon secretion

AU - Fujimoto, W. Y.

AU - Ensinck, J. W.

AU - Johnson, David G

PY - 1977

Y1 - 1977

UR - http://www.scopus.com/inward/record.url?scp=0017370163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017370163&partnerID=8YFLogxK

M3 - Article

VL - 26

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - Sup 1

ER -